| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| 06/12/2013 | CN103153956A Novel processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide |
| 06/12/2013 | CN103153955A Pyridine compounds and the uses thereof |
| 06/12/2013 | CN103153945A 1-hydroxyimino-3-phenyl-propanes |
| 06/12/2013 | CN103153917A Thionation process and thionating agent |
| 06/12/2013 | CN103153308A TRPA1 receptor antagonist |
| 06/12/2013 | CN103145612A Method for preparing N-oxide-2-chloropyridine and for recycling and reusing catalyst |
| 06/12/2013 | CN103145611A 1,6-dihydro-2-methyl-6-oxygen-(3,4'-dipyridine)-5-methyl formate and preparation method thereof |
| 06/12/2013 | CN103145610A Preparation method of 3-(2-pyridine amino) ethyl propionate |
| 06/12/2013 | CN103145609A Preparation method of 2,3-dichloropyridine |
| 06/12/2013 | CN103145583A Raceme alkannin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative and preparation and application thereof |
| 06/12/2013 | CN102249990B Process for synthesizing 6-(trifluoromethyl)pyridine-3-carboxaldehyde |
| 06/12/2013 | CN102229560B Cis-nitenpyram compound including 1,3-dicarbonyl, preparation method and use |
| 06/12/2013 | CN102225909B Preparation method of lansoprazole intermediate |
| 06/12/2013 | CN102127010B Preparation method of greenish yellow light-emitting material using pyridine as donor unit |
| 06/12/2013 | CN102050689B Method for preparing beta-amino-alpha,beta unsaturated ester |
| 06/12/2013 | CN101932562B Carbamoyl compounds as dgat1 inhibitors 190 |
| 06/12/2013 | CN101883757B Method for producing 6-halogeno-3-arylpyridine derivative |
| 06/12/2013 | CN101704701B Method for reducing alkyne into cis-form olefin |
| 06/12/2013 | CN101600683B Therapeutic compounds |
| 06/12/2013 | CN101522623B Non-flushing niacin analogues, and methods of use thereof |
| 06/12/2013 | CN101410370B Selective hydroxamate based MMP inhibitors |
| 06/12/2013 | CN101379140B Photosensitizer dye |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/12/2013 | CN101258138B Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands |
| 06/11/2013 | US8461347 Process for preparing form A of atazanavir sulfate |
| 06/11/2013 | US8461345 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides) |
| 06/11/2013 | US8461344 Polymorph forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropdxypyridin)yl]-4-penten-2-amine |
| 06/11/2013 | US8461343 Synthesis of thiohydantoins |
| 06/11/2013 | US8461189 Pyridyl derivatives as histone deacetylase inhibitors |
| 06/11/2013 | US8461183 PPAR agonist compounds, preparation and uses |
| 06/11/2013 | US8460397 Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a pyridine and derivatives thereof |
| 06/11/2013 | CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 06/11/2013 | CA2577837C Diarylsulfones as 5-ht2a antagonists |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/06/2013 | WO2013080215A1 An improved process for the preparation of flupirtine and pharmaceutically acceptable salts thereof |
| 06/06/2013 | WO2013079616A1 Benzyl-pyridinium and -imidazolinium ionic liquid salts for use in planar chromatography |
| 06/06/2013 | WO2013079514A1 Sulphur-free transition metal-isocyanate-based ionic liquids |
| 06/06/2013 | WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 06/06/2013 | WO2013024040A3 Tnf superfamily trimerization inhibitors |
| 06/06/2013 | US20130144056 Human Adam-10 Inhibitors |
| 06/06/2013 | US20130143933 Targeted correction of a genetic defect in cancer therapy |
| 06/06/2013 | US20130143932 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 06/06/2013 | US20130143898 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | DE102011055859A1 Schwefel-freie Übergangsmetall-Isocyanat-basierte ionische Flüssigkeiten Sulfur-free transition metal isocyanate-based ionic liquids |
| 06/05/2013 | EP2599769A1 Method for producing carboxylic acid amide |
| 06/05/2013 | EP2598483A1 Ampk-activating heterocyclic compounds and methods for using the same |
| 06/05/2013 | EP2598482A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 06/05/2013 | EP2598481A1 Sulfonamide compounds useful as cyp17 inhibitors |
| 06/05/2013 | EP2598480A1 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 06/05/2013 | EP2598158A1 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex |
| 06/05/2013 | CN103140496A Carboxylate metal complex and catalyst for olefin polymerization |
| 06/05/2013 | CN103140486A Co-crystals and salts of ccr3-inhibitors |
| 06/05/2013 | CN103140476A Novel trpv3 modulators |
| 06/05/2013 | CN103140474A Napht- 2 -ylacetic acid derivatives to treat aids |
| 06/05/2013 | CN103140221A Novel heterocyclic derivatives and pharmaceutical composition containing same |
| 06/05/2013 | CN103130745A Diaryl-piperazines compound and medical application thereof |
| 06/05/2013 | CN103130718A Magnetic ion liquid, preparation method of magnetic ion liquid and application of magnetic ion liquid |
| 06/05/2013 | CN103130715A Novel compounding method of hioacetamide compound |
| 06/05/2013 | CN103130714A Fullerene radical malonamide benzyloxy-pyridone derivative and preparation method thereof |
| 06/05/2013 | CN103130713A Synthesis method for 4, 4'-dibromo-2, 2'-dipyridyl |
| 06/05/2013 | CN103130712A Paraquat hapten, paraquat complete antigen and preparation method of paraquat hapten and paraquat complete antigen |
| 06/05/2013 | CN103130696A Anthranilamide compound as well as preparation method and application thereof |
| 06/05/2013 | CN103130686A N,N'-asymmetric diayl substitution urea compound and preparation method and purpose thereof |
| 06/05/2013 | CN103130680A High-optical-purity alkannin and Akannin naphthazarin nuclear parent hydroxyl methylation carbonyl oxime derivative and preparation method and application thereof |
| 06/05/2013 | CN102295595B Method for producing pyridine compound |
| 06/05/2013 | CN102093287B Aminopyridine alkyl xanthate derivatives and preparation method and use thereof |
| 06/05/2013 | CN101870705B Novel organic compound, light-emitting device, and image display apparatus |
| 06/05/2013 | CN101723883B Method for preparing oxycodone |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/04/2013 | US8455656 Kinase inhibitors |
| 06/04/2013 | US8455655 Preparation of dihydropyridines |
| 06/04/2013 | US8455654 Nanosized particles of benzimidazolone pigments |
| 06/04/2013 | US8455649 Insecticidal substituted azinyl derivatives |
| 06/04/2013 | US8455501 N-(5-cycloalkyl)-pyridin-3-yl carboxamides |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455398 Amide compounds, preparation methods and uses thereof |
| 06/04/2013 | CA2692028C Azapeptide derivatives |
| 06/04/2013 | CA2562152C Process for the production of cyclic diketones |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 05/30/2013 | WO2013075624A1 Glycine reuptake inhibitor and use thereof |
| 05/30/2013 | US20130137731 Ethanamine compounds and methods of using the same |
| 05/30/2013 | US20130137704 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 05/30/2013 | US20130137699 Therapeutic compounds |
| 05/30/2013 | US20130137690 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 05/30/2013 | US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same |
| 05/30/2013 | US20130137660 Inhibitors of kinase activity |
| 05/30/2013 | US20130137648 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 05/30/2013 | US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 05/30/2013 | CA2855980A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 05/29/2013 | EP2597085A1 Organic compounds |
| 05/29/2013 | EP2597083A2 Selective hydroxamate based MMP inhibitors |
| 05/29/2013 | EP2596789A1 Oral medicinal composition for patients undergoing peritoneal dialysis and method for using same |
| 05/29/2013 | EP2596785A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/29/2013 | EP2595975A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 05/29/2013 | EP2595959A1 Sulfonyl compounds which modulate the cb2 receptor |
| 05/29/2013 | EP2595958A2 Novel processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide |
| 05/29/2013 | EP2595957A1 Pyridin- 2 - yl sulfanyl acid esters and process for the preparation thereof |